µå·¯±×ÀÎÆ÷¸ÞÀÎ
 

»óº´Äڵ忡 µû¸¥ »óº´¸íÀ» È®ÀÎ ÇϽǼö ÀÖ½À´Ï´Ù.  
»óº´ÄÚµå ÇÑ±Û»óº´¸í ¿µ¹®»óº´¸í
Y555 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â °¨±â¾à Anti-common-cold drugs causing adverse effects in therapeutic use
Y556 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº Ç×õ½ÄÁ¦ Antiasthmatics, NEC causing adverse effects in therapeutic use
Y556 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¾Æ¹Ì³ëÇʸ° Aminophylline causing adverse effects in therapeutic use
Y556 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ìºÎŸ¸ô Salbutamol causing adverse effects in therapeutic use
Y556 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ƽ¿ÀºÎ·Î¹Î Theobromine causing adverse effects in therapeutic use
Y556 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Å׿ÀÇʸ° Theophylline causing adverse effects in therapeutic use
Y557 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÀÏÂ÷ÀûÀ¸·Î È£Èí°èÅë¿¡ ÀÛ¿ëÇÏ´Â ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ Á¦Á¦ Other and unspecified agents primarily acting on the respiratory system causing adverse effects in therapeutic use
Y56 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÀÏÂ÷ÀûÀ¸·Î ÇǺΠ¹× Á¡¸·¿¡ ÀÛ¿ëÇÏ´Â ¾àÁ¦¿Í ¾È°úÀû, À̺ñÀÎÈÄ°úÀû ¹× Ä¡°úÀû Á¦Á¦ Agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs causing adverse effects in therapeutic use
Y56 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±¹¼ÒÀûÀ¸·Î »ç¿ëµÈ ±Û·çÄÚÄÚ¸£Æ¼ÄÚÀ̵å Glucocorticoids, topically used causing adverse effects in therapeutic use
Y560 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ±¹¼Ò Ç×Áø±ÕÁ¦, Ç×°¨¿°Á¦ ¹× Ç׿°ÁõÁ¦ Local antifungal, anti-infective and anti-inflammatory drugs, NEC causing adverse effects in therapeutic use
Y561 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×°¡·Á¿òÁ¦ Antipruritics causing adverse effects in therapeutic use
Y562 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±¹¼Ò¼ö·ÅÁ¦ ¹× ±¹¼Ò¼¼Á¤Á¦ Local astringents and local detergents causing adverse effects in therapeutic use
Y563 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¿ÏÈ­Á¦, Á¡È°Á¦ ¹× º¸È£Á¦ Emollients, demulcents and protectants causing adverse effects in therapeutic use
Y564 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â °¢Áú¿ëÇØÁ¦, °¢ÁúÇü¼ºÁ¦ ¹× ±âŸ ¸ð¹ßÄ¡·á ¾à¹° ¹× Á¦Á¦ Keratolytics, keratoplastic and other hair treatment drugs and preparations causing adverse effects in therapeutic use
Y565 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¾È°ú ¾à¹° ¹× Á¦Á¦ Ophthalmological drugs and preparations causing adverse effects in therapeutic use
Y566 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â À̺ñÀÎÈÄ°ú ¾à¹° ¹× Á¦Á¦ Otorhinolaryngological drugs and preparations causing adverse effects in therapeutic use
Y567 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±¹¼ÒÀûÀ¸·Î ¹Ù¸£´Â Ä¡°ú ¾àÁ¦ Dental durgs, topically applied causing adverse effects in therapeutic use
Y568 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ±¹¼Ò¼º Á¦Á¦ Other topical agents causing adverse effects in therapeutic use
Y568 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ìÁ¤ÀÚÁ¦ Spermicides causing adverse effects in therapeutic use
Y569 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ó¼¼ºÒ¸íÀÇ ±¹¼Ò Á¦Á¦ Topical agent, unspecified causing adverse effects in therapeutic use
3881  3882  [3883] 3884  3885  3886  3887  3888  3889  3890